The main findings of our study highlighted the presence of CB1R in the exosomes extracted from the plasma of NAFLD patients and its crucial role in the modulation of hepatic cells’ function. This evidence concerns the gene CNR1 and metabolic dysfunction-associated steatotic liver disease.